THE BIONIC EYE

Abstract

 ABSTRACT Aim of bionic eye is to restore vision to patients who have gone blind due to macular degeneration or retinitis pigmentosa. In the past 20 years, biotechnology has become the fastest-growing area of scientific research, with new devices going into clinical trials at a breakneck pace.2013 has been a year of turning science fiction into reality. One technology that immediately comes to mind is the bionic eye. While in the works for years, the first artificial retina and surgical implant procedure were just recently approved by the FDA. Designed by Second Sight, the Argus II Retinal Prosthesis System uses camera-mounted glasses to turn visual information into data that can be wirelessly transmitted to the bionic implant on the eye. The device has been specifically designed for – and testing with – patients who suffer from retinitis pigmentosa: an inherited degenerative disease leading to severe deterioration of sight or total blindness. Around 1.5 million people worldwide suffer from the condition, including 100,000 America. The Argus II Retinal Prosthesis System can provide sight -- the detection of light -- to people who have gone blind from degenerative eye diseases like macular degeneration and retinitis pigmentosa. Ten percent of people over the age of 55 suffer from various stages of macular degeneration. Retinitis pigmentosa is an inherited disease that affects about 1.5 million people around the globe. Both diseases damage the eyes' photoreceptors, the cells at the back of the retina that perceive light patterns and pass them on to the brain in the form of nerve impulses, where the impulse patterns are then interpreted as images. The Argus II system takes the place of these photoreceptors. Keywords: Bionic eye, Retinitis pigmentosa, Photoreceptors

Authors and Affiliations

Satya Mounika CH. V. V.

Keywords

Related Articles

 NOVEL SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL STUDIES OF SCHIFF BASE COMPLEXES OF 4-PYRIDINE CARBOXALDEHYDE

 ABSTRACT In the present study an intermolecular reductive Schiff base formation from 4-nitro pyridine and 4 pyridine carboxaldehyde carried out in the presence of iron powder and dilute acid. The Schiff base and...

 DIVERSE THERAPEUTIC APPLICATIONS OF ALOEVERA: A REVIEW

 Many of the health benefits associated with Aloe vera have been attributed to the polysaccharides contained in the gel ofthe leaves. These biological activities include effects promotion of wound healing, antifunga...

 ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF LEAF EXTRACT OF MORINDA CITRIFOLIA IN EXPERIMENTAL MODELS

 Morinda citrifolia is a medium sized evergreen tree belongs to Rubiaceae family. The petroleum ether extract ofMorinda citrifolia (PMC) leaves was investigated for the evaluation of anti- inflammatory and analgesic...

ENHANCEMENT SOLUBILITY AND DISSOLUTION OF MEFENAMIC ACID BY MODIFIED STARCH

 The objective of the present research work is to enhance the dissolution profile of the mefenamic acid by Modified Starch as a carrier. Starch citrate was prepared by reacting the citric acid with starch at elevate...

 FORMULATION AND EVALUATION OF GLIMEPIRIDE MICROSPHERES

 The present study is an attempt to formulate microspheres of Glimepiride, an orally administered ant-diabetic drug with a view of improving its oral bioavailability and giving a prolonged release of drug, where h...

Download PDF file
  • EP ID EP154194
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Satya Mounika CH. V. V. (2015).  THE BIONIC EYE. International Journal of Pharmaceutical Development & Technology, 5(1), 52-60. https://europub.co.uk/articles/-A-154194